Revolution Medicines shares promising data around KRAS drug combination

fiercepharma.com·Jul 7, 2026 · 1 mese fa

Bristol lays out KRAS med Krazati's stumble in confirmatory colorectal cancer trial

morningstar.com·Jul 2, 2026 · 1 mese fa

Genentech’s Divarasib Shows Superiority in Head-to-Head Phase III Trial Against Approved KRAS G12C Inhibitors in Non-Small Cell Lung Cancer

biopharmadive.com·Jul 2, 2026 · 1 mese fa

Roche KRAS drug succeeds in head-to-head lung cancer study